Drug pricing agreements have saved the developing world more than $1 billion.

Working with the governments of developing countries and the pharmaceutical industry, the Clinton Health Access Initiative (CHAI), a separate, affiliated entity, has helped dramatically lower the cost of lifesaving medicines and diagnostics for HIV/AIDS, malaria, and tuberculosis. Globally, CHAI negotiates price reductions for drugs and diagnostics, customize products for resource-limited settings, and work to broaden the supply base and increase the quality of these treatments.

Learn more about the Clinton Health Access Initiative's work in Global Health